Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection
Maen, Abdelrahim, Gok Yavuz, Betul, Mohamed, Yehia I, Esmail, Abdullah, Lu, Jianming, Mohamed, Amr, Azmi, Asfar S, Kaseb, Mohamed, Kasseb, Osama, Li, Dan, Gocio, Michelle, Kocak, Mehmet, Selim, Abdelhafez, Ma, Qing, Kaseb, Ahmed O
Published in Frontiers in pharmacology (06.02.2024)
Published in Frontiers in pharmacology (06.02.2024)
Get full text
Journal Article
The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 Infection
Kaseb, Ahmed O, Mohamed, Yehia I, Malek, Alexandre E, Raad, Issam I, Altameemi, Lina, Li, Dan, Kaseb, Omar A, Kaseb, Safa A, Selim, Abdelhafez, Ma, Qing
Published in Pathogens (Basel) (22.03.2021)
Published in Pathogens (Basel) (22.03.2021)
Get full text
Journal Article
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of ThymoQuinone Formula (TQF) for Treating Outpatient SARS-CoV-2
Bencheqroun, Hassan, Ahmed, Yasir, Kocak, Mehmet, Villa, Enrique, Barrera, Cesar, Mohiuddin, Mariya, Fortunet, Raul, Iyoha, Emmanuel, Bates, Deborah, Okpalor, Chinedu, Agbosasa, Ola, Mohammed, Karim, Pondell, Stephen, Mohamed, Amr, Mohamed, Yehia I, Gok Yavuz, Betul, Kaseb, Mohamed O, Kasseb, Osama O, Gocio, Michelle York, Tu, Peter Tsu-Man, Li, Dan, Lu, Jianming, Selim, Abdulhafez, Ma, Qing, Kaseb, Ahmed O
Published in Pathogens (Basel) (07.05.2022)
Published in Pathogens (Basel) (07.05.2022)
Get full text
Journal Article